利博西克利布诱导的肝炎:可能发生自身免疫性肝毒性的病例报告
Jennifer Leigh1, Jordan Rivera1, Maryam Alsulaiman1
1Medical Oncology, Mount Sinai Hospital, Toronto, ON, Canada.
Case reports in oncology
|December 1, 2025
概括
激素受体阳性乳腺癌患者经历里博西基利布的肝损伤可能受益于皮质类固醇治疗和切换到abemaciclib. 这种方法为管理治疗诱导的肝毒性提供了一个安全的替代方案.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 激素受体阳性乳腺癌是最常见的亚型.
- 转移性疾病的第一线治疗包括内分泌疗法和CDK4/6抑制剂.
- 利博西克利布是一种常用的CDK4/6抑制剂,具有很高的肝毒性风险.
研究的目的:
- 报告与 ribociclib.lib. 治疗的患者发生严重的亚胺转移炎的病例.
- 讨论对 ribociclib 诱导的肝毒性的管理.
- 评估切换到另一种CDK4/6抑制剂的安全性和有效性.
主要方法:
- 一个59岁的女性患有转移性乳腺癌的病例介绍.
- 用富尔韦斯特兰特和里博西基利布治疗,其次是剂量中断和对透氨炎的皮质类固醇治疗.
- 用较低剂量的 ribociclib 重新挑战,然后切换到 abemaciclib.
主要成果:
- 患者在开始服用 ribociclib.lib 后出现了 3 级透氨酸炎.
- 皮质类固醇治疗导致肝酶的改善.
- 随着 ribociclib 的重新挑战导致了复发性透氨炎,而 abemaciclib 则被耐受,没有肝毒性.
结论:
- 利博西克利布诱导的肝毒性可能具有免疫介导的组成部分,对皮质类固醇有反应.
- 切换到不同的CDK4/6抑制剂,如abemaciclib,对于患有肝毒性患者来说,这是一个安全有效的策略.
- 这一案例凸显了考虑替代CDK4/6抑制剂在治疗相关不良事件管理中的重要性.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241
Hepatic Drug Excretion: Enterohepatic Cycling
2.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.6K
Myocarditis I: Introduction
343
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
343
Hepatic Drug Excretion: Influencing Factors
508
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
508


